Published: 2022-11-25

Study on awareness and perception towards adverse drug reactions among medical and paramedical students in South India

Anjali Sruthi S., Muhas C., Keerthi S., Anagha T. R., Abhishek K. M., Anupama E. V., Haritha T.


Background: Pharmacovigilance (PV) programme targets the monitoring of safety of drugs. It aims at promoting patient care and improving public health and also helps to assess the risk-benefit profile of medicines. The aim of the study was to assess public knowledge about medicine information, safety, and adverse drug reaction reporting (ADR) in medical and paramedical student community.

Methods: It was a cross-sectional study conducted among medical and paramedical students for the period of six months from November 2021 to April 2022. The questionnaire was adopted from the literature and was validated. Content and face validities were established, and reliability was assessed. In this study a total of 364 participants returned completed questionnaires.

Results: In this study, 364 students completely filled the questionnaire and out of 364 participants, 155 were males (42.58%) and 209 (57.41%) were females. Fourth year students 131 (35.98%) are highly participated in this study and indicated that final year B Pharmacy students having the perceptive knowledge towards ADR. Majority of medical and paramedical students known well about the ADRs.

Conclusions: The results of this study highlighted that although the scores for knowledge of medicines, and tendency to report ADR were better, the score for knowledge regarding medication safety was unsatisfactory. There is a need for a regular training and the re-enforcement for the ADR reporting among the health care personnel both medical and paramedical students.  


Adverse drug reaction, Medical students, Monitoring, Pharmacovigilance, Reporting systems, Medication safety

Full Text:



Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15-9.

Lihite RJ, Lahkar M. An update on the Pharmacovigilance Programme of India. Front Pharmacol. 2015;6:194.

Ganesan S, Sandhiya S, Reddy KC, Subrahmanyam DK, Adithan C. The Impact of the Educational Intervention on Knowledge, Attitude, and Practice of Pharmacovigilance toward Adverse Drug Reactions Reporting among Health-care Professionals in a Tertiary Care Hospital in South India. J Nat Sci Biol Med. 2017;8(2):203-9.

Sultana J, Cutroneo P, Trifirò G. Clinical and economic burden of adverse drug reactions. J Pharmacol Pharmacother. 2013;4(1):S73-7.

Zheng R, Tao L, Kwong JSW, Zhong C, Li C, Chen S, et al. Risk factors associated with the severity of adverse drug reactions by Xiyanping injection: A propensity score-matched analysis. J Ethnopharmacol. 2020;250:112424.

Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother. 2008;42(7):1017-25.

Munasinghe TM, Singer DR. Costs and prevention of adverse drug reactions. Eur J Intern Med. 2001;12(5):403-5.

Tandon VR, Mahajan V, Khajuria V, Gillani Z. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India. Indian J Pharmacol. 2015;47(1):65-71.

Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2009;32(1):19-31.

Stergiopoulos S, Brown CA, Felix T, Grampp G, Getz KA. A Survey of Adverse Event Reporting Practices Among US Healthcare Professionals. Drug Saf. 2016;39(11):1117-27.

Hardeep, Bajaj JK, Rakesh K. A survey on the knowledge, attitude and the practice of pharmacovigilance among the health care professionals in a teaching hospital in northern India. J Clin Diagn Res. 2013;7(1):97-9.

Conforti A, Costantini D, Zanetti F, Moretti U, Grezzana M, Leone R. Adverse drug reactions in older patients: an Italian observational prospective hospital study. Drug Healthc Patient Saf. 2012;4:75-80.

Alhawassi TM, Abuelizz HA, Almetwazi M, Mahmoud MA, Alghamdi A, Alruthia YS, et al. Advancing pharmaceuticals and patient safety in Saudi Arabia: A 2030 vision initiative. Saudi Pharm J. 2018;26(1):71-4.

Dukes MN. The importance of adverse reactions in drug regulation. Drug Saf. 1990;5(1):3-6.

Reumerman M, Tichelaar J, Piersma B, Richir MC, Agtmael MA. Urgent need to modernize pharmacovigilance education in healthcare curricula: review of the literature. Eur J Clin Pharmacol. 2018;74(10):1235-48.